leisure time -WSS

leisure time

author：fashion 2025-10-01 17:20:48 - browse：24

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： David Ricks of Eli Lilly: best biopharma CEO of 2023

hotspot

explore

knowledge

WSS

NIH director takes cautious approach to Biden drug pricing priority

SNAP should offer more nutrition education

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Three trends to watch in biotech in 2024

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Francis Collins on trust in science and how Covid communications failed

leisure time

leisure time

explore

Peter Hotez and the public health issue of online harassment

HCA sued by state AG for quality issues at Mission Health

The high cost of giving birth even with insurance

Editas, Vertex strike deal on CRISPR

Medical records are filled with copy

EU regulator recommends expanding Mounjaro approval to obesity

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Francis Collins on trust in science and how Covid communications failed

Cancer drug shortages should be causing more outrage

New brain studies show LSD's effects on the brain in full color

hotspot

FDA clears AI tool for detecting skin cancer

NIH director takes cautious approach to Biden drug pricing priority

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

NIH director takes cautious approach to Biden drug pricing priority

Prior authorization will have to move faster under new Biden rule

The surgeon had a dilemma only a Nazi medical text could resolve

hotspot

explore

knowledge

hotspot